These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

114 related items for PubMed ID: 2579055

  • 1. Amplification of the antibiotic effects of the bleomycins, phleomycins and tallysomycins: its dependence on the nature of the variable basic groups.
    Grigg GW, Hall RM, Hart NK, Kavulak DR, Lamberton JA, Lane A.
    J Antibiot (Tokyo); 1985 Jan; 38(1):99-110. PubMed ID: 2579055
    [Abstract] [Full Text] [Related]

  • 2. Identification of a Tn5 determinant conferring resistance to phleomycins, bleomycins, and tallysomycins.
    Collis CM, Hall RM.
    Plasmid; 1985 Sep; 14(2):143-51. PubMed ID: 2415995
    [Abstract] [Full Text] [Related]

  • 3. Amplifications of phleomycin and bleomycin-induced antibiotic activity in Escherichia coli by aromatic cationic compounds.
    Grigg GW, Gero AM, Hughes JM, Sasse WH, Bliese M, Hart NK, Johansen O, Kissane P.
    J Antibiot (Tokyo); 1977 Oct; 30(10):870-8. PubMed ID: 73539
    [Abstract] [Full Text] [Related]

  • 4. An Escherichia coli mutant resistant to phleomycin, bleomycin, and heat inactivation is defective in ubiquinone synthesis.
    Collis CM, Grigg GW.
    J Bacteriol; 1989 Sep; 171(9):4792-8. PubMed ID: 2475481
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Differences in sensitivity of T3, T7, T4 and lambda phages to bleomycin and phleomycin].
    Scholz D, Meissner C, Rosenthal HA.
    Z Allg Mikrobiol; 1979 Sep; 19(10):745-52. PubMed ID: 94958
    [Abstract] [Full Text] [Related]

  • 12. Platomycins A and B II. Physicochemical properties.
    Takasawa S, Kawamoto I, Sato S, Yahashi R, Okachi R.
    J Antibiot (Tokyo); 1975 Sep; 28(9):662-7. PubMed ID: 52649
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Tallysomycin, a new antitumor antibiotic complex related to bleomycin. II. Structure determination of tallysomycins A and B.
    Konishi M, Saito K, Numata K, Tsuno T, Asama K.
    J Antibiot (Tokyo); 1977 Oct; 30(10):789-805. PubMed ID: 591444
    [Abstract] [Full Text] [Related]

  • 15. Isolation and partial characterization of mutants of Saccharomyces cerevisiae altered in sensitivities to lethal effects of bleomycins.
    Moore CW.
    J Antibiot (Tokyo); 1980 Nov; 33(11):1369-75. PubMed ID: 6166602
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Amplification of the antitumor activity of phleomycins in rats and mice by heterocyclic analogues of purines.
    Allen TE, Brown DJ, Cowden WB, Grigg GW, Hart NK, Lamberton JA, Lane A.
    J Antibiot (Tokyo); 1984 Apr; 37(4):376-83. PubMed ID: 6202668
    [Abstract] [Full Text] [Related]

  • 20. Control of in vivo (cellular) phleomycin sensitivity by nuclear genotype, growth phase, and metal ions.
    Moore CW.
    Cancer Res; 1982 Mar; 42(3):929-33. PubMed ID: 6174219
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.